''I'm a human being first, and a star second.'' + An interview with Vladimir Malakhov

被引：0
|
作者：
Regitz, H
Malakhov, V
机构：
来源：
BALLETT INTERNATIONAL-TANZ AKTUELL | 1997年 / 02期
关键词：
D O I：
暂无
中图分类号：
J7 [舞蹈];
学科分类号：
摘要：
引用
收藏
页码：26 / 29
页数：4
相关论文
共 50 条
  • [21] Dear Isobel, I have my first interview next month and I'm very worried about having to talk about myself. It's not easy for me, can you help?
    Brown, I
    IEE REVIEW, 2003, 49 (01): : 27 - 27
  • [22] 'It feels like I'm back to being a teacher': A longitudinal trajectory analysis of teachers' experiences during the first 8 months of COVID-19 in England
    Kim, Lisa E. E.
    Fields, Diana
    Asbury, Kathryn
    BRITISH JOURNAL OF EDUCATIONAL PSYCHOLOGY, 2023, 93 (04) : 1105 - 1122
  • [23] Research on the relationship among Human Being, Building and Environment-Take I. M. Pei's Architectural Design Works for Example
    Guo, Liqun
    ARCHITECTURE, BUILDING MATERIALS AND ENGINEERING MANAGEMENT, PTS 1-4, 2013, 357-360 : 238 - 241
  • [24] How first-time-in-human studies are being performed: A survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004
    Buoen, C
    Bjerrum, OJ
    Thomsen, MS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (10): : 1123 - 1136
  • [25] Phase I/II, first in human trial with M7583, a Bruton's tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies
    Jurczak, W.
    Rule, S.
    Townsend, W.
    Tucker, D.
    Sarholz, B.
    Scheele, J.
    Gribben, J.
    Zinzani, P. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies
    Jurczak, Wojciech
    Rule, Simon
    Townsend, William
    Tucker, David
    Sarholz, Barbara
    Scheele, Juergen
    Dyroff, Martin
    Gribben, John G.
    Dlugosz-Danecka, Monika
    Zinzani, Pier Luigi
    LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2392 - 2399
  • [27] A Phase I/III, First in Human Trial of the Bruton's Tyrosine Kinase Inhibitor M7583 in Patients with B-Cell Malignancies
    Jurczak, Wojciech
    Rule, Simon
    Townsend, William
    Tucker, David
    Sarholz, Barbara
    Scheele, Jurgen
    Gribben, John G.
    Zinzani, Pier Luigi
    BLOOD, 2018, 132
  • [28] Phase I/II, first in human trial of the Bruton's tyrosine kinase inhibitor (BTKi) M7583 in patients with B cell malignancies.
    Rule, Simon
    Tucker, David
    Kalapur, Anup
    Sarholz, Barbara
    Scheele, Jurgen
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer
    Xingsheng Hu
    Xin Zheng
    Sheng Yang
    Lin Wang
    Xuezhi Hao
    Xinge Cui
    Lieming Ding
    Li Mao
    Pei Hu
    Yuankai Shi
    Journal of Hematology & Oncology, 13
  • [30] First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer
    Hu, Xingsheng
    Zheng, Xin
    Yang, Sheng
    Wang, Lin
    Hao, Xuezhi
    Cui, Xinge
    Ding, Lieming
    Mao, Li
    Hu, Pei
    Shi, Yuankai
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
12345